157 related articles for article (PubMed ID: 15024037)
1. [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.
Jarvis MF; Bianchi B; Uchic JT; Cartmell J; Lee CH; Williams M; Faltynek C
J Pharmacol Exp Ther; 2004 Jul; 310(1):407-16. PubMed ID: 15024037
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Ca2+ influx through recombinant P2X receptor in C6BU-1 cells.
Ueno S; Koizumi S; Inoue K
Br J Pharmacol; 1998 Aug; 124(7):1484-90. PubMed ID: 9723962
[TBL] [Abstract][Full Text] [Related]
3. Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors.
Virginio C; Robertson G; Surprenant A; North RA
Mol Pharmacol; 1998 Jun; 53(6):969-73. PubMed ID: 9614197
[TBL] [Abstract][Full Text] [Related]
4. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
[TBL] [Abstract][Full Text] [Related]
5. 2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.
Neelands TR; Burgard EC; Uchic ME; McDonald HA; Niforatos W; Faltynek CR; Lynch KJ; Jarvis MF
Br J Pharmacol; 2003 Sep; 140(1):202-10. PubMed ID: 12967950
[TBL] [Abstract][Full Text] [Related]
6. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
7. [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.
Donnelly-Roberts DL; Namovic MT; Surber B; Vaidyanathan SX; Perez-Medrano A; Wang Y; Carroll WA; Jarvis MF
Neuropharmacology; 2009 Jan; 56(1):223-9. PubMed ID: 18602931
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist.
McGaraughty S; Jarvis MF
Drug News Perspect; 2005 Oct; 18(8):501-7. PubMed ID: 16391720
[TBL] [Abstract][Full Text] [Related]
9. Molecular physiology of P2X receptors.
North RA
Physiol Rev; 2002 Oct; 82(4):1013-67. PubMed ID: 12270951
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
Tiberi M; Magnan J
Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
[TBL] [Abstract][Full Text] [Related]
11. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
12. P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices.
Papp L; Balázsa T; Köfalvi A; Erdélyi F; Szabó G; Vizi ES; Sperlágh B
J Pharmacol Exp Ther; 2004 Sep; 310(3):973-80. PubMed ID: 15084650
[TBL] [Abstract][Full Text] [Related]
13. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
15. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of cloned P2X receptors.
North RA; Surprenant A
Annu Rev Pharmacol Toxicol; 2000; 40():563-80. PubMed ID: 10836147
[TBL] [Abstract][Full Text] [Related]
17. Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors.
Varani K; Surprenant A; Vincenzi F; Tosi A; Gessi S; Merighi S; Borea PA
Biochem Pharmacol; 2008 Mar; 75(5):1198-208. PubMed ID: 18076867
[TBL] [Abstract][Full Text] [Related]
18. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
[TBL] [Abstract][Full Text] [Related]
19. A-317491, a selective P2X3/P2X2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats.
Wu G; Whiteside GT; Lee G; Nolan S; Niosi M; Pearson MS; Ilyin VI
Eur J Pharmacol; 2004 Nov; 504(1-2):45-53. PubMed ID: 15507220
[TBL] [Abstract][Full Text] [Related]
20. Myocardial ischemic nociceptive signaling mediated by P2X3 receptor in rat stellate ganglion neurons.
Zhang C; Li G; Liang S; Xu C; Zhu G; Wang Y; Zhang A; Wan F
Brain Res Bull; 2008 Jan; 75(1):77-82. PubMed ID: 18158099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
